Cancer is the second leading cause of death after cardiovascular diseases. Conventional
anticancer therapies are associated with lack of selectivity and serious side effects. Cancer …

Chronic liver disease (CLD) is a continuous process that causes a reduction of liver function
lasting more than six months. CLD includes alcoholic liver disease (ALD), non-alcoholic fatty …

Ulcerative colitis (UC) is an inflammatory bowel disease with characteristic inflammation to
mucosal cells in rectum and colon leading to lesions in mucosa and submucosa. Moreover …

Natural products can generally exhibit a variety of biological activities, but most show
mediocre performance in preliminary activity evaluation. Natural products often require …

Ulcerative colitis (UC) is an inflammatory bowel disease that affects the mucosa of the colon,
resulting in severe inflammation and ulcers. Genistein is a polyphenolic isoflavone present …

Objectives Gastric ulcer (GU) is a prevalent chronic digestive disease affecting about 10% of
the world's population leading to gastrointestinal perforation and bleeding. Genistein is a …

Inflammatory bowel disease (IBD) is a special chronic intestinal inflammatory disease, which
is mainly divided into Crohn's disease (CD) and ulcerative colitis (UC). Its occurrence is a …

Background and aims Hepatocellular carcinoma (HCC) is one of the most common
malignancies in the world and the sixth leading cause of cancer death worldwide, and it is …

Background Cancer is the second-leading cause of death worldwide. According to a 2018
WHO report, 9.6 million deaths occurred globally due to cancer. Ehrlich carcinoma is …

The most promising avenues for improving conventional drugs are those based on
biocompatible organic compounds. These bioactive compounds can be isolated from …